Valeant Makes Skin Care Licensing Deal Amid Allergan Offer

, The Am Law Daily

   | 0 Comments

Six Am Law 100 firms are advising as Valeant sells the licensing rights to several skin care products to Nestle for $1.4 billion as it ups its unsolicited bid for Botox maker Allergan.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202657112486

Thank you!

This article's comments will be reviewed.